Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600

Corporate Action
โดย PR Newswire·Read original
Summary · why it matters

S&P Dow Jones Indices announced that Krystal Biotech will move from the S&P SmallCap 600 to the S&P MidCap 400, replacing Taylor Morrison Home effective prior to the opening of trading on Friday, July 24. Tutor Perini will take Krystal Biotech's place in the S&P SmallCap 600 on the same date. The changes are driven by Berkshire Hathaway's acquisition of Taylor Morrison Home, which is expected to close on or about July 24. Additionally, V2X will replace Avanos Medical in the S&P SmallCap 600 effective prior to the opening of trading on Monday, July 27, as American Industrial Partners acquires Avanos Medical in a deal expected to close soon.

Impact on stocks 8

Cloud & Digital Infrastructure▲ · 2 stocks
Biotech & Genomic Medicine▲ · 1 stocks
Krystal Biotech Inc
KRYS
▲ PositiveCapitalrelevance

Krystal Biotech is being added to the S&P MidCap 400 index, which typically attracts passive fund inflows and enhances visibility.

Industrials▲ · 1 stocks
Tutor Perini Corporation
TPC
▲ PositiveCapitalrelevance

Tutor Perini is being added to the S&P SmallCap 600 index, which typically attracts passive fund inflows and enhances visibility.

Defense & Geopolitical Fragmentation▲ · 1 stocks
V2X Inc
VVX
▲ PositiveCapitalrelevance

V2X is being added to the S&P SmallCap 600 index, which typically attracts passive fund inflows and enhances visibility.

Health Care▲ · 1 stocks
Energy Transition & Power Demand▲ · 1 stocks
Consumer Discretionary▲ · 1 stocks

Off-coverage companies 1

American Industrial PartnersPrivate± Mixed
relevance

© 2026 MarketDXNews